The breast imaging market is a vital sector within medical diagnostics, dedicated to the early detection and diagnosis of breast-related abnormalities, including breast cancer. This market encompasses a diverse array of imaging modalities such as mammogram, ultrasound, magnetic resonance imaging (MRI), and molecular breast imaging. With breast cancer being a prevalent global health concern, the demand for advanced and accurate diagnostic tools ultrasound in the field of breast imaging is consistently growing. Mammography remains a cornerstone in breast cancer screening, while innovations like digital mammography and tomosynthesis contribute to enhanced imaging capabilities.

Technological advancements, particularly in the development of 3D mammography and contrast-enhanced imaging techniques, play a pivotal role in improving the sensitivity and specificity of breast imaging. Additionally, the integration of artificial intelligence (AI) in image interpretation is revolutionizing the efficiency and accuracy of breast cancer detection. Rising awareness, proactive screening programs, and increased healthcare investments further drive the market. The emphasis on patient comfort and the reduction of radiation exposure also shapes the evolving landscape of breast imaging. As breast health awareness continues to grow globally, the breast imaging market is poised for continued expansion, with ongoing research and development efforts focused on refining diagnostic accuracy and advancing personalized treatment strategies.

The global breast imaging market share is considered to demonstrate 8.3% CAGR during the forecast period (2023-2030) owing to increasing prevalence of breast cancer, asserts Market Research Future (MRFR). Breast imaging is referred to a diagnostic procedure which evaluates the presence of breast tumor in women. Breast biopsy ultrasound, mammography, PET, CT, MRI, tactile imaging, and others are some of the common breast imaging procedures. Among these, mammography is the most widely used screening tool and diagnosis for breast cancer and helps to detect breast cancer at an early stage. According to the World Health Organization, breast cancer has been reported as the second most common cancer among the women population.

Drivers and Constraints Impacting the Market

With the rising prevalence of breast cancer, the global breast imaging market is anticipated to flourish during the assessment period. More than 200,000 new cases of cancer are diagnosed every year across the globe. The increasing expenditure on healthcare by the developed countries coupled with the technological developments in the field of oncology across the world has further contributed to the market growth. Moreover, the emergence of new imaging technologies for screening and diagnosis of several chronic diseases have mostly influenced the market growth. Several companies conduct corporate social responsibility activities to help women educate regarding breast health and its preventive measures. For instance, companies like GE Healthcare have recently launched a commercial regarding the awareness of breast density and its effect on screening techniques. With the increasing awareness, the demand for breast imaging is predicted to expand in during the appraisal period.

On the flip side, the high cost of breast imaging solutions coupled with the unawareness about breast imaging among the women population are predicted to dampen the market growth during the estimated period. Moreover, most of the women are reluctant to undergo breast imaging owing to a number of misconceptions about the disease. This is considered to restrict the market growth in the coming years.

Competitive Dashboard

The prominent players operating the global breast imaging market are Sonocine Inc. (U.S.), Fujifilm Holdings Corporation (Japan), General Electric Company (U.K.), Hologic Inc. (U.S.), Dilon Technologies Inc. (U.S.), Gamma Medica Inc. (U.S.), Toshiba Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Siemens (Germany), Aurora Imaging Technology Inc. (U.S.), and others.

Global Breast Imaging Market: Segmental Analysis

The global breast imaging market has been segmented on the basis of type, application, deployment, end-user, and region.

By mode of type, the global breast imaging market has been segmented into CT, mammography, MRI, PET, breast biopsy, ultrasound, tactile imaging, and others. Among these, the mammography segment has been further sub-segmented into full-field digital mammography (FFDM), film-screen mammography, scintimammography or molecular breast imaging, 3D mammography, and others. The breast biopsy segment has been sub-segmented into tactic core biopsy, image-guided breast biopsy, ultrasound-guided core biopsy, and others.

By mode of application, the global breast imaging market has been segmented into post-neoadjuvant chemotherapy, breast cancer diagnosis, metastatic axillary adenocarcinoma, and others.

By mode of end-user, the global breast imaging market has been segmented into diagnostic centers, hospitals, and others.

Regional Insights

Geographically, the breast imaging market insights span across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Among all the regions, America is considered to be the largest market for breast imaging. The growth is attributed to the growing prevalence for breast cancer, innovative imaging solutions for breast imaging, and development of new imaging devices by the major market players. The market in the North American region is driven by the extensive use of imaging modalities like CT, mammography, and MRI for screening of breast cancer. The U.S. is considered to hold the largest market share owing to the presence of major players coupled with emphasis on women healthcare.

The European market is presumed to exhibit a significant growth owing to an increased expenditure on research and development activities by the major countries like U.K. The market in Germany is expanding at a substantial rate owing to an extensive use of available imaging technologies for breast imaging coupled with the exponential growth of medical devices industry. Moreover, the urge of developing new imaging devices for early cancer screening is also considered to contribute to the market growth in this region.

The Asia Pacific region showcases numerous growth opportunities owing to the presence of some of the largest contributors such as China, Japan, and India. With rising awareness about breast cancer along with the use of medical devices for cancer screening, the breast imaging market is likely to accelerate in this region. Moreover, the rapid growth of healthcare imaging industry in China and India and rising government support for improvement in the diagnostic services and healthcare infrastructure contributes to the market growth.

Read More: https://www.marketresearchfuture.com/